Abstract 102: Racial, Gender, and Socioeconomic Differences in Sacubitril-valsartan and Ivabradine Utilization for the Management of Heart Failure With Reduced Ejection Fraction in The United States
Background: Current guidelines for heart failure with reduced ejection fraction (HFrEF) recommend transition to an angiotensin receptor-neprilysin inhibitor (ARNI) from
Read more
